Liposomal methylprednisolone differentially regulates the expression of TNF and IL-10 in human alveolar macrophages

International Immunopharmacology

Volumn 5, Issue 2, 2005, Pages 289-299

  Frankenberger, Marion ^a   Häussinger, Karl ^a   Ziegler Heitbrock, Löms ^a,b  

^a Clin Coop Grp Inflammatory L   (Germany)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Alveolar macrophages; Glucocorticoids; IL 10; Liposomes; TNF

Indexed keywords

BLOOD CLOTTING FACTOR 7; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; LIPOSOME; MESSENGER RNA; METHYLPREDNISOLONE; THROMBOPLASTIN; TUMOR NECROSIS FACTOR;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG FORMULATION; FEMALE; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-10; LIPOSOMES; LUNG DISEASES; MACROPHAGES, ALVEOLAR; MALE; METHYLPREDNISOLONE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 12344321698     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.09.033     Document Type: Article

References (18)

1. S.P. Umland, R.P. Schleimer, and S.L. Johnston Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma Pulm. Pharmacol. Ther. 15 2002 35 50
2. R.H. Oakley, C.M. Jewell, M.R. Yudt, D.M. Bofetiado, and J.A. Cidlowski The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action J. Biol. Chem. 274 1999 27857 27866
3. I.J. Brogan, I.A. Murray, G. Cerillo, M. Needham, A. White, and J.R. Davis Interaction of glucocorticoid receptor isoforms with transcription factors AP-1 and NF-kappaB: lack of effect of glucocorticoid receptor beta Mol. Cell. Endocrinol. 157 1999 95 104
4. P.J. Barnes Mechanisms of action of glucocorticoids in asthma Am. J. Respir. Crit. Care Med. 154 1996 S21 S26 (discussion S26-S27)
5. R.A. Pauwels, A.S. Buist, P.M. Calverley, C.R. Jenkins, and S.S. Hurd Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary Am. J. Respir. Crit. Care Med. 163 2001 1256 1276
6. P.J. Barnes, S. Pedersen, and W.W. Busse Efficacy and safety of inhaled corticosteroids. New developments Am. J. Respir. Crit. Care Med. 157 1998 S1 53
7. S. Pedersen, and P. O'Byrne A comparison of the efficacy and safety of inhaled corticosteroids in asthma Allergy 52 1997 1 34
8. C.A. Sorkness Establishing a therapeutic index for the inhaled corticosteroids: Part II. Comparisons of systemic activity and safety among different inhaled corticosteroids J. Allergy Clin. Immunol. 102 1998 S52 S64
9. T. Fushimi, H. Okayama, T. Seki, S. Shimura, and K. Shirato Dexamethasone suppressed gene expression and production of interleukin-10 by human peripheral blood mononuclear cells and monocytes Int. Arch. Allergy Immunol. 112 1997 13 18
10. J. Visser, A. van Boxel-Dezaire, D. Methorst, T. Brunt, E.R. de Kloet, and L. Nagelkerken Differential regulation of interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro Blood 91 1998 4255 4264
11. M. Frankenberger, R.W. Hauck, B. Frankenberger, K. Haussinger, K.L. Maier, and J. Heyder All trans-retinoic acid selectively down-regulates matrix metalloproteinase-9 (MMP-9) and up-regulates tissue inhibitor of metalloproteinase-1 (TIMP-1) in human bronchoalveolar lavage cells Mol. Med. 7 2001 263 270
12. A. Gayo, L. Mozo, A. Suarez, A. Tunon, C. Lahoz, and C. Gutierrez Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse J. Neuroimmunol. 85 1998 122 130
13. Y. Tabardel, J. Duchateau, D. Schmartz, G. Marecaux, M. Shahla, and L. Barvais Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men Surgery 119 1996 76 80
14. P. Dandona, A. Aljada, R. Garg, and P. Mohanty Increase in plasma interleukin-10 following hydrocortisone injection J. Clin. Endocrinol. Metab. 84 1999 1141 1144
15. M. John, S. Lim, J. Seybold, P. Jose, A. Robichaud, and B. O'Connor Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1 alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma Am. J. Respir. Crit. Care Med. 157 1998 256 262
16. G.M. Tremblay, H.M. Therien, H. Rocheleau, and Y. Cormier Liposomal dexamethasone effectiveness in the treatment of hypersensitivity pneumonitis in mice Eur. J. Clin. Invest. 23 1993 656 661
17. E.V. Mishina, and W.J. Jusko Liposomal methylprednisolone in rats: dose-proportionality and chronic-dose pharmacokinetics/pharmacodynamics Pharm. Res. 13 1996 141 145
18. J.C. Waldrep, B.E. Gilbert, C.M. Knight, M.B. Black, P.W. Scherer, and V. Knight Pulmonary delivery of beclomethasone liposome aerosol in volunteers. tolerance and safety Chest 111 1997 316 323